| NCT ID | NCT03178552 |
| Title | A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) (B-FAST) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | yes |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies |
Carboplatin + Cisplatin + Gemcitabine |
| Age Groups: | senior adult |